{"entity":{"type":"insider","cik":"0001500595","url":"/insider/0001500595","json_url":"/insider/0001500595.json","name":"KPCB XIII Associates, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":2,"first":"2014-02-12","last":"2021-04-19","span_basis":"filed_date"},"name_variants":[{"name":"KPCB XIII Associates, LLC","source":"filing","n_filings":2,"first_seen":"2014-02-12","last_seen":"2021-04-19"}],"transactions":[{"id":4409851,"accession":"0001104659-21-052085","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-052085","line_url":"/filing/0001104659-21-052085","is_derivative":false,"issuer_cik":"0001435899","issuer_name":"Progyny, Inc.","issuer_ticker":"PGNY","issuer_name_source":null,"issuer_url":"/issuer/0001435899","owner_cik":null,"owner_name":"KPCB XIII Associates, LLC; KLEINER PERKINS CAUFIELD & BYERS XIII, LLC","owner_display_name":"KPCB XIII Associates, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18127.0,"shares_display":"18,127","price_per_share":50.32,"price_display":"50.32","price_state":"stated","total_value":912150.64,"total_display":"912,150.64","total_whole":"912,151","shares_owned_after":8805015.0,"shares_owned_after_display":"8,805,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-15","filed_date":"2021-04-19","scope":"insider","n_lines":2},{"id":6445809,"accession":"0001435899-14-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001435899-14-000003","line_url":"/filing/0001435899-14-000003#line-1","is_derivative":false,"issuer_cik":"0001435899","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001435899","owner_cik":null,"owner_name":"KLEINER PERKINS CAUFIELD & BYERS XIII, LLC; KPCB XIII Associates, LLC","owner_display_name":"KLEINER PERKINS CAUFIELD & BYERS XIII, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":388584.0,"shares_display":"388,584","price_per_share":27.6413,"price_display":"27.64","price_state":"stated","total_value":10740966.9192,"total_display":"10,740,966.92","total_whole":"10,740,967","shares_owned_after":3838167.0,"shares_owned_after_display":"3,838,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-10","filed_date":"2014-02-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001551306","name":"Progyny, Inc.","url":"/issuer/0001551306","role":"Ten percent owner","n_filings":1,"first_seen":"2021-04-19","last_seen":"2021-04-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001571498","name":"Epizyme, Inc.","url":"/issuer/0001571498","role":"Ten percent owner","n_filings":1,"first_seen":"2014-02-12","last_seen":"2014-02-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001500595","retrieved_at":"2026-08-22T08:41:54+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}